GABA-enriched fermented Laminaria japonica improves cognitive impairment and neuroplasticity in scopolamine- and ethanol-induced dementia model mice.
10.4162/nrp.2018.12.3.199
- Author:
Storm N S REID
1
;
Je kwang RYU
;
Yunsook KIM
;
Byeong Hwan JEON
Author Information
1. Department of Physical Education, School of Sports and Health, Kyungsung University, 309, Suyeong-ro, Nam-gu, Busan 48434, Korea. mooaworld@hotmail.com
- Publication Type:Original Article
- Keywords:
Fermented laminaria;
cognitive dysfunction;
acetylcholine;
cyclic AMP response element;
muscarinic receptors
- MeSH:
Acetylcholine;
Acetylcholinesterase;
Alanine Transaminase;
Animals;
Aspartate Aminotransferases;
Blotting, Western;
Brain;
Cholesterol;
Cognition Disorders*;
Cyclic AMP Response Element-Binding Protein;
Dementia*;
Drug Therapy;
Ethanol;
Extracellular Signal-Regulated MAP Kinases;
Functional Food;
Hippocampus;
Immunohistochemistry;
Laminaria*;
Memory;
Mice*;
Neurodegenerative Diseases;
Neuronal Plasticity*;
Neuroprotective Agents;
Receptors, Muscarinic;
Scopolamine Hydrobromide;
Triglycerides;
United Nations;
Water
- From:Nutrition Research and Practice
2018;12(3):199-207
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND/OBJECTIVES: Fermented Laminaria japonica (FL), a type sea tangle used as a functional food ingredient, has been reported to possess cognitive improving properties that may aid in the treatment of common neurodegenerative disorders, such as dementia. MATERIALS/METHODS: We examined the effects of FL on scopolamine (Sco)- and ethanol (EtOH)-induced hippocampus-dependent memory impairment, using the Passive avoidance (PA) and Morris water maze (MWM) tests. To examine the underlying mechanisms associated with neuroprotective effects, we analyzed acetylcholine (ACh) and acetylcholinesterase (AChE) activity, brain tissue expression of muscarinic acetylcholine receptor (mAChR), cAMP response element binding protein (CREB) and extracellular signal-regulated kinases 1/2 (ERK1/2), and immunohistochemical analysis, in the hippocampus of mice, compared to current drug therapy intervention. Biochemical blood analysis was carried out to determine the effects of FL on alanine transaminase (ALT), aspartate transaminase (AST), and triglyceride (TG) and total cholesterol (TC) levels. 7 groups (n = 10) consisted of a control (CON), 3 Sco-induced dementia and 3 EtOH-induced dementia groups, with both dementia group types containing an untreated group (Sco and EtOH); a positive control, orally administered donepezil (Dpz) (4mg/kg) (Sco + Dpz and EtOH + Dpz); and an FL (50 mg/kg) treatment group (Sco + FL50 and EtOH + FL50), orally administered over the 4-week experimental period. RESULTS: FL50 significantly reduced EtOH-induced increase in AST and ALT levels. FL50 treatment reduced EtOH-impaired step-through latency time in the PA test, and Sco- and EtOH-induced dementia escape latency times in the MWM test. Moreover, anticholinergic effects of Sco and EtOH on the brain were reversed by FL50, through the attenuation of AChE activity and elevation of ACh concentration. FL50 elevated ERK1/2 protein expression and increased p-CREB (ser133) in hippocampus brain tissue, according to Western blot and immunohistochemistry analysis, respectively. CONCLUSION: Overall, these results suggest that FL may be considered an efficacious intervention for Sco- and EtOH-induced dementia, in terms of reversing cognitive impairment and neuroplastic dysfunction.
